tiprankstipranks
Nuvalent (NUVL)
NASDAQ:NUVL
US Market

Compare Nuvalent (NUVL) vs. Competitors

172 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Compare
Top Analysts' Price Target
Smart Score
Follow
Nuvalent
$102.74
$8.08B
-17.19
65.74%
15 Buy
0 Hold
0 Sell
Strong Buy
Cytokinetics
$65.01
$8.01B
-9.72
71.76%
16 Buy
2 Hold
0 Sell
Strong Buy
TG Therapeutics
$33.73
$5.39B
9.62
-6.25%
3 Buy
1 Hold
1 Sell
Moderate Buy
Axsome Therapeutics
$178.11
$9.11B
-49.60
86.21%
16 Buy
1 Hold
0 Sell
Strong Buy
Atrium Therapeutics, Inc.
$12.71
-3.29
-13.83%
1 Buy
0 Hold
0 Sell
Moderate Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
NUVL
Nuvalent
102.74
32.74
46.77%
CYTK
Cytokinetics
65.01
25.20
63.30%
TGTX
TG Therapeutics
33.73
-4.68
-12.18%
AXSM
Axsome Therapeutics
178.11
74.58
72.04%
MRUS
RNA
Atrium Therapeutics, Inc.
12.71
-2.04
-13.83%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts